What's Happening?
The START Center for Cancer Research has appointed Dr. Navid Hafez as the Director of Clinical Research at its new Los Angeles site. This site is part of a strategic partnership with the Los Angeles Cancer Network, soon to be Oncura Health, which is one
of the largest community-based oncology practices in the U.S. Dr. Hafez brings extensive experience in early-phase oncology trials and will lead efforts to integrate clinical research with patient care. The new site aims to enhance access to innovative cancer treatments and trials for a diverse patient population in Southern California.
Why It's Important?
The appointment of Dr. Hafez and the establishment of the new START site in Los Angeles are significant for advancing cancer research and treatment accessibility. By embedding clinical trials within a large community-based oncology practice, START aims to provide patients with early access to cutting-edge therapies. This approach can potentially improve treatment outcomes and expand research opportunities. The initiative reflects a broader trend in healthcare towards integrating research with clinical practice to accelerate the development of new treatments and improve patient care.
What's Next?
The new START site in Los Angeles is expected to conduct numerous early-phase clinical trials, contributing to the development of novel cancer therapies. As the site becomes operational, it will likely attract collaborations with pharmaceutical companies and research institutions. The focus will be on expanding trial access and increasing diversity in clinical research participation. This development may also influence other oncology practices to adopt similar models, promoting a more integrated approach to cancer care and research.
